277 related articles for article (PubMed ID: 29622035)
1. CCL17 blockade as a therapy for osteoarthritis pain and disease.
Lee MC; Saleh R; Achuthan A; Fleetwood AJ; Förster I; Hamilton JA; Cook AD
Arthritis Res Ther; 2018 Apr; 20(1):62. PubMed ID: 29622035
[TBL] [Abstract][Full Text] [Related]
2. Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice.
Lee KM; Prasad V; Achuthan A; Fleetwood AJ; Hamilton JA; Cook AD
Osteoarthritis Cartilage; 2020 Apr; 28(4):486-491. PubMed ID: 32028021
[TBL] [Abstract][Full Text] [Related]
3. TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17.
Cook AD; Lee MC; Saleh R; Khiew HW; Christensen AD; Achuthan A; Fleetwood AJ; Lacey DC; Smith JE; Förster I; Hamilton JA
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563337
[TBL] [Abstract][Full Text] [Related]
4. The GM-CSF/CCL17 pathway in obesity-associated osteoarthritic pain and disease in mice.
Shin H; Prasad V; Lupancu T; Malik S; Achuthan A; Biondo M; Kingwell BA; Thiem M; Gottschalk M; Weighardt H; Förster I; de Steiger R; Hamilton JA; Lee KM
Osteoarthritis Cartilage; 2023 Oct; 31(10):1327-1341. PubMed ID: 37225052
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation.
Achuthan A; Cook AD; Lee MC; Saleh R; Khiew HW; Chang MW; Louis C; Fleetwood AJ; Lacey DC; Christensen AD; Frye AT; Lam PY; Kusano H; Nomura K; Steiner N; Förster I; Nutt SL; Olshansky M; Turner SJ; Hamilton JA
J Clin Invest; 2016 Sep; 126(9):3453-66. PubMed ID: 27525438
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF- and IRF4-Dependent Signaling Can Regulate Myeloid Cell Numbers and the Macrophage Phenotype during Inflammation.
Lee MC; Lacey DC; Fleetwood AJ; Achuthan A; Hamilton JA; Cook AD
J Immunol; 2019 May; 202(10):3033-3040. PubMed ID: 30988114
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.
van Dalen SC; Blom AB; Slöetjes AW; Helsen MM; Roth J; Vogl T; van de Loo FA; Koenders MI; van der Kraan PM; van den Berg WB; van den Bosch MH; van Lent PL
Osteoarthritis Cartilage; 2017 Mar; 25(3):385-396. PubMed ID: 27654963
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and transcriptional regulation of IL4-induced CCL17 production in human monocytes and murine macrophages.
Hsu AT; Lupancu TJ; Lee MC; Fleetwood AJ; Cook AD; Hamilton JA; Achuthan A
J Biol Chem; 2018 Jul; 293(29):11415-11423. PubMed ID: 29871928
[TBL] [Abstract][Full Text] [Related]
9. IL-23 in arthritic and inflammatory pain development in mice.
Lee KM; Zhang Z; Achuthan A; Fleetwood AJ; Smith JE; Hamilton JA; Cook AD
Arthritis Res Ther; 2020 May; 22(1):123. PubMed ID: 32471485
[TBL] [Abstract][Full Text] [Related]
10. The role of NOX2-derived reactive oxygen species in collagenase-induced osteoarthritis.
van Dalen SCM; Kruisbergen NNL; Walgreen B; Helsen MMA; Slöetjes AW; Cremers NAJ; Koenders MI; van de Loo FAJ; Roth J; Vogl T; Blom AB; van der Kraan PM; van Lent PLEM; van den Bosch MHJ
Osteoarthritis Cartilage; 2018 Dec; 26(12):1722-1732. PubMed ID: 30195046
[TBL] [Abstract][Full Text] [Related]
11. CCL17 in Inflammation and Pain.
Lee KM; Jarnicki A; Achuthan A; Fleetwood AJ; Anderson GP; Ellson C; Feeney M; Modis LK; Smith JE; Hamilton JA; Cook A
J Immunol; 2020 Jul; 205(1):213-222. PubMed ID: 32461237
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development.
Cook AD; Pobjoy J; Steidl S; Dürr M; Braine EL; Turner AL; Lacey DC; Hamilton JA
Arthritis Res Ther; 2012 Sep; 14(5):R199. PubMed ID: 22995428
[TBL] [Abstract][Full Text] [Related]
13. Expression of granulocyte macrophage-colony stimulating factor and its receptor in the synovium of osteoarthritis patients is negatively correlated with pain.
van Helvoort EM; Eijkelkamp N; Lafeber FPJG; Mastbergen SC
Rheumatology (Oxford); 2020 Nov; 59(11):3452-3457. PubMed ID: 32365364
[TBL] [Abstract][Full Text] [Related]
14. CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons.
Fülle L; Offermann N; Hansen JN; Breithausen B; Erazo AB; Schanz O; Radau L; Gondorf F; Knöpper K; Alferink J; Abdullah Z; Neumann H; Weighardt H; Henneberger C; Halle A; Förster I
Glia; 2018 Oct; 66(10):2246-2261. PubMed ID: 30277599
[TBL] [Abstract][Full Text] [Related]
15. S100A8/A9 increases the mobilization of pro-inflammatory Ly6C
Cremers NAJ; van den Bosch MHJ; van Dalen S; Di Ceglie I; Ascone G; van de Loo F; Koenders M; van der Kraan P; Sloetjes A; Vogl T; Roth J; Geven EJW; Blom AB; van Lent PLEM
Arthritis Res Ther; 2017 Sep; 19(1):217. PubMed ID: 28969686
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain.
Cook AD; Pobjoy J; Sarros S; Steidl S; Dürr M; Lacey DC; Hamilton JA
Ann Rheum Dis; 2013 Feb; 72(2):265-70. PubMed ID: 22833372
[TBL] [Abstract][Full Text] [Related]
17. Alarmin S100A9 Induces Proinflammatory and Catabolic Effects Predominantly in the M1 Macrophages of Human Osteoarthritic Synovium.
van den Bosch MH; Blom AB; Schelbergen RF; Koenders MI; van de Loo FA; van den Berg WB; Vogl T; Roth J; van der Kraan PM; van Lent PL
J Rheumatol; 2016 Oct; 43(10):1874-1884. PubMed ID: 27481901
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation.
Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA
Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288
[TBL] [Abstract][Full Text] [Related]
19. CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
Feng G; Bajpai G; Ma P; Koenig A; Bredemeyer A; Lokshina I; Lai L; Förster I; Leuschner F; Kreisel D; Lavine KJ
Circulation; 2022 Mar; 145(10):765-782. PubMed ID: 35113652
[TBL] [Abstract][Full Text] [Related]
20. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
